MedPath

Harris Teeter Redness Relief Eye Drops

Harris Teeter Redness Relief Eye Drops15mL (PLD)

Approved
Approval ID

31a3d575-10f1-5feb-e063-6294a90ac478

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Jan 1, 2024

Manufacturers
FDA

Harris Teeter, LLC.

DUNS: 048463103

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Glycerin, Naphazoline hydrochloride

PRODUCT DETAILS

NDC Product Code69256-979
Application NumberM018
Marketing CategoryC200263
Route of AdministrationOPHTHALMIC
Effective DateJanuary 1, 2024
Generic NameGlycerin, Naphazoline hydrochloride

INGREDIENTS (7)

BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
GLYCERINActive
Quantity: 0.25 g in 100 mL
Code: PDC6A3C0OX
Classification: ACTIB
NAPHAZOLINE HYDROCHLORIDEActive
Quantity: 0.012 g in 100 mL
Code: MZ1131787D
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BORATEInactive
Code: 91MBZ8H3QO
Classification: IACT
BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Harris Teeter Redness Relief Eye Drops - FDA Drug Approval Details